PE20000428A1 - Nuevas dihidropirimidinas 2 heterociclicamente sustituidas - Google Patents

Nuevas dihidropirimidinas 2 heterociclicamente sustituidas

Info

Publication number
PE20000428A1
PE20000428A1 PE1999000310A PE00031099A PE20000428A1 PE 20000428 A1 PE20000428 A1 PE 20000428A1 PE 1999000310 A PE1999000310 A PE 1999000310A PE 00031099 A PE00031099 A PE 00031099A PE 20000428 A1 PE20000428 A1 PE 20000428A1
Authority
PE
Peru
Prior art keywords
halogen
optionally substituted
trifluoromethyl
alkyl
phenyl optionally
Prior art date
Application number
PE1999000310A
Other languages
English (en)
Inventor
Siegfried Goldmann
Jurgen Stoltefuss
Erwin Graef
Stefan Lottmann
Arnold Paessens
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of PE20000428A1 publication Critical patent/PE20000428A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

SE REFIERE A DIHIDROPIRIMIDINAS DE FORMULA I, DONDE R1 ES FENILO, FURILO, TIENILO, PIRIDILO, CICLOALQUILO C3-C6, ANILLO a, b, c OPCIONALMENTE SUSTITUIDOS CON HALOGENO, TRIFLUOROMETILO, NITRO, CIANO, -S-R6, NR7R8, CO-NR9R10, SO2-CF3, -A-CH2-R11, ENTRE OTROS; R6 ES FENILO OPCIONALMENTE SUSTITUIDO CON HALOGENO; R7, R8, R9 Y R10 SON H, FENILO OPCIONALMENTE SUSTITUIDO CON HIDROXI, ACILO C1-C6, ALQUILO C1-C6; A ES O, S, SO, SO2; R11 ES FENILO OPCIONALMENTE SUSTITUIDO CON HALOGENO, NITRO, TRIFLUOROMETILO, ENTRE OTROS; R2 ES -OR12, NR13R14; R12 ES H, ALCOXI C1-C6(CARBONILO), UN GRUPO HIDROCARBONADO C1-C8; R3 ES H, AMINO, -C-(OCH3)2-, FORMILO, CIANO, TRIFLUOROMETILO, UN RESTO HIDROCARBURO; R4 ES H, ALQUILO C1-C4, ACETILO, BENZOILO; D ES O o S; R5 ES H, HALOGENO, ALQUILO C1-C6. TAMBIEN SE REFIERE A UN PROCEDIMIENTO PARA LA PREPARACION. EL COMPUESTO I TIENE ACTIVIDAD ANTIVIRAL CONTRA EL VIRUS DE LA HEPATITIS B (HBV), POR LO QUE PUEDE SER UTIL PARA EL TRATAMIENTO Y PROFILAXIS DE INFECCIONES CRONICAS Y AGUDAS POR HEPATITIS B
PE1999000310A 1998-04-18 1999-04-15 Nuevas dihidropirimidinas 2 heterociclicamente sustituidas PE20000428A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19817262A DE19817262A1 (de) 1998-04-18 1998-04-18 Neue 2-heterocyclisch substituierte Dihydropyrimidine

Publications (1)

Publication Number Publication Date
PE20000428A1 true PE20000428A1 (es) 2000-06-25

Family

ID=7864971

Family Applications (1)

Application Number Title Priority Date Filing Date
PE1999000310A PE20000428A1 (es) 1998-04-18 1999-04-15 Nuevas dihidropirimidinas 2 heterociclicamente sustituidas

Country Status (16)

Country Link
US (1) US6503913B1 (es)
EP (1) EP1073653B1 (es)
JP (1) JP2002512244A (es)
KR (1) KR20010042787A (es)
CN (1) CN1134434C (es)
AR (1) AR015765A1 (es)
AU (1) AU3420599A (es)
CA (1) CA2328876A1 (es)
DE (2) DE19817262A1 (es)
ES (1) ES2181413T3 (es)
GT (1) GT199900055A (es)
HK (1) HK1037188A1 (es)
ID (1) ID26308A (es)
PE (1) PE20000428A1 (es)
SV (1) SV1999000049A (es)
WO (1) WO1999054329A1 (es)

Families Citing this family (56)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000058302A1 (de) * 1999-03-25 2000-10-05 Bayer Aktiengesellschaft Dihydropyrimidine und ihre verwendung zur behandlung von hepatitis b
EP1193259A4 (en) 1999-06-23 2003-01-29 Ajinomoto Kk dihydropyrimidine
WO2001045712A1 (de) * 1999-12-22 2001-06-28 Bayer Aktiengesellschaft Arzneimittelkombinationen gegen virale erkrankungen
DE10012549A1 (de) * 2000-03-15 2001-09-20 Bayer Ag Arzneimittel gegen virale Erkrankungen
DE10012824A1 (de) * 2000-03-16 2001-09-20 Bayer Ag Arzneimittel gegen virale Erkrankungen
DE10012823A1 (de) 2000-03-16 2001-09-20 Bayer Ag Arzneimittel gegen virale Erkrankungen
DE10013125A1 (de) * 2000-03-17 2001-09-20 Bayer Ag Arzneimittel gegen virale Erkrankungen
AU2007231012B2 (en) * 2006-03-24 2013-07-04 The Feinstein Institute For Medical Research Phenolic hydrazone macrophage migration inhibitory factor inhibitors
CN101104617B (zh) * 2006-07-10 2010-06-23 北京摩力克科技有限公司 二氢嘧啶类化合物及其用于制备治疗和预防病毒性疾病的药物的用途
CN101104604B (zh) * 2006-07-10 2011-03-02 北京摩力克科技有限公司 光学纯二氢嘧啶类化合物及其用于制备治疗和预防病毒性疾病的药物的用途
CN100453542C (zh) * 2007-04-30 2009-01-21 广东东阳光药业有限公司 2-杂环取代的二氢嘧啶消旋化合物的拆分方法
PT2159224E (pt) 2007-06-18 2012-10-24 Sunshine Lake Pharma Co Ltd Tiazolil dihidropirimidinas substituídas com bromo-fenilo
WO2008154820A1 (fr) * 2007-06-18 2008-12-24 Zhang, Zhongneng Thiazolyl-dihydropyrimidines à substitution carbéthoxy
CN101328170B (zh) * 2007-06-18 2011-09-14 张中能 一种氟苯基-取代噻唑二氢嘧啶
WO2010069147A1 (zh) * 2008-12-17 2010-06-24 张中能 二氢嘧啶类化合物、其组合物及其应用
CN104302626B (zh) * 2012-01-06 2016-09-07 爱尔兰詹森科学公司 4,4-二取代的-1,4-二氢嘧啶及其作为治疗乙型肝炎的药物的用途
WO2013119895A1 (en) * 2012-02-08 2013-08-15 Sunovion Pharmaceuticals Inc. Heteroaryl compounds and methods of use thereof
RU2014142598A (ru) * 2012-03-31 2016-05-27 Ф. Хоффманн-Ля Рош Аг Новые 4-метилдигидропиримидины для лечения и профилактики инфекции вируса гепатита в
US20130267517A1 (en) 2012-03-31 2013-10-10 Hoffmann-La Roche Inc. Novel 4-methyl-dihydropyrimidines for the treatment and prophylaxis of hepatitis b virus infection
CN104926808B (zh) 2012-08-24 2018-09-14 广东东阳光药业有限公司 二氢嘧啶类化合物及其在药物中的应用
CN103664925B (zh) * 2012-09-07 2018-01-23 广东东阳光药业有限公司 杂芳基取代的二氢嘧啶类化合物及其在药物中的应用
CA2881322A1 (en) 2012-09-10 2014-03-13 F. Hoffmann-La Roche Ag 6-amino acid heteroaryldihydropyrimidines for the treatment and prophylaxis of hepatitis b virus infection
AU2014352404B2 (en) 2013-11-19 2018-07-19 Sunshine Lake Pharma Co., Ltd. Dihydropyrimidine compounds and their application in pharmaceuticals
JP6434511B2 (ja) * 2013-11-27 2018-12-05 サンシャイン・レイク・ファーマ・カンパニー・リミテッドSunshine Lake Pharma Co.,Ltd. ジヒドロピリミジン誘導体およびその中間体の製造方法
US9771358B2 (en) 2014-03-28 2017-09-26 Sunshine Lake Pharma Co., Ltd. Dihydropyrimidine compounds and their application in pharmaceuticals
EP3253751B1 (en) 2015-02-07 2020-12-09 Sunshine Lake Pharma Co., Ltd. Complexes and salts of dihydropyrimidine derivatives and their application in pharmaceuticals
US10442788B2 (en) 2015-04-01 2019-10-15 Enanta Pharmaceuticals, Inc. Hepatitis B antiviral agents
WO2016183266A1 (en) 2015-05-13 2016-11-17 Enanta Pharmaceuticals, Inc. Ehpatitis b antiviral agents
WO2017011552A1 (en) 2015-07-13 2017-01-19 Enanta Pharmaceuticals, Inc. Hepatitis b antiviral agents
US10301255B2 (en) 2015-07-22 2019-05-28 Enanta Pharmaceuticals, Inc. Hepatitis B antiviral agents
EP3353190B1 (en) 2015-09-23 2021-03-17 Reata Pharmaceuticals, Inc. C4-modified oleanolic acid derivatives for inhibition of il-17 and other uses
CN108368113B (zh) * 2015-11-04 2020-11-24 齐鲁制药有限公司 二氢吡啶并环化合物的晶型、制备方法和中间体
US10280175B2 (en) 2016-02-02 2019-05-07 Enanta Pharmaceuticals, Inc. Hepatitis B antiviral agents
ES2938341T3 (es) 2016-03-07 2023-04-10 Enanta Pharm Inc Agentes antivirales contra la hepatitis B
SG11201810834WA (en) * 2016-06-10 2018-12-28 Enanta Pharm Inc Hepatitis b antiviral agents
UA125519C2 (uk) 2016-07-29 2022-04-13 Суновіон Фармасьютікалз Інк. Сполуки і композиції і їх застосування
SG11201900687VA (en) 2016-07-29 2019-02-27 Sunovion Pharmaceuticals Inc Compounds and compositions and uses thereof
CA3070993A1 (en) 2017-08-02 2019-02-07 Sunovion Pharmaceuticals Inc. Isochroman compounds and uses thereof
CN107501257B (zh) * 2017-08-17 2020-05-29 山东大学 二氢嘧啶-三氮唑类衍生物及其制备方法与应用
EA202090514A1 (ru) 2017-08-28 2020-06-24 Энанта Фармасьютикалс, Инк. Противовирусное средство против гепатита в
CA3079557A1 (en) * 2017-10-18 2019-04-25 Sunshine Lake Pharma Co., Ltd. Dihydropyrimidine compounds and uses thereof in medicine
US10723733B2 (en) 2017-12-06 2020-07-28 Enanta Pharmaceuticals, Inc. Hepatitis B antiviral agents
TW201927789A (zh) 2017-12-06 2019-07-16 美商因那塔製藥公司 B型肝炎抗病毒試劑
US11058678B2 (en) 2018-01-22 2021-07-13 Enanta Pharmaceuticals, Inc. Substituted heterocycles as antiviral agents
US10729688B2 (en) 2018-03-29 2020-08-04 Enanta Pharmaceuticals, Inc. Hepatitis B antiviral agents
US10865211B2 (en) 2018-09-21 2020-12-15 Enanta Pharmaceuticals, Inc. Functionalized heterocycles as antiviral agents
KR20210093951A (ko) 2018-11-21 2021-07-28 이난타 파마슈티칼스, 인코포레이티드 항바이러스제로서의 작용화된 헤테로사이클
AU2020236225A1 (en) 2019-03-14 2021-09-16 Sunovion Pharmaceuticals Inc. Salts of a isochromanyl compound and crystalline forms, processes for preparing, therapeutic uses, and pharmaceutical compositions thereof
US11236111B2 (en) 2019-06-03 2022-02-01 Enanta Pharmaceuticals, Inc. Hepatitis B antiviral agents
US11760755B2 (en) 2019-06-04 2023-09-19 Enanta Pharmaceuticals, Inc. Hepatitis B antiviral agents
WO2020247575A1 (en) 2019-06-04 2020-12-10 Enanta Pharmaceuticals, Inc. Hepatitis b antiviral agents
US11738019B2 (en) 2019-07-11 2023-08-29 Enanta Pharmaceuticals, Inc. Substituted heterocycles as antiviral agents
US11236108B2 (en) 2019-09-17 2022-02-01 Enanta Pharmaceuticals, Inc. Functionalized heterocycles as antiviral agents
CN112707910A (zh) * 2019-10-24 2021-04-27 广东东阳光药业有限公司 二氢嘧啶类化合物及其在药物中的应用
WO2021188414A1 (en) 2020-03-16 2021-09-23 Enanta Pharmaceuticals, Inc. Functionalized heterocyclic compounds as antiviral agents
CN113512035B (zh) * 2021-04-26 2023-11-24 山东大学 二氢嘧啶-泊马度胺缀合物及其制备方法与应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH550189A (de) 1971-01-08 1974-06-14 Ciba Geigy Ag Verfahren zur herstellung von neuen dibenzo (b,f) thiepincarbonsaeuren.
CH569043A5 (es) 1973-01-23 1975-11-14 Ciba Geigy Ag
DE3234684A1 (de) 1982-09-18 1984-03-22 Bayer Ag, 5090 Leverkusen Neue dihydropyrimidine, verfahren zu ihrer herstellung sowie ihre verwendung in arzneimitteln

Also Published As

Publication number Publication date
DE19817262A1 (de) 1999-10-21
WO1999054329A1 (de) 1999-10-28
DE59902470D1 (de) 2002-10-02
JP2002512244A (ja) 2002-04-23
EP1073653A1 (de) 2001-02-07
SV1999000049A (es) 2000-07-04
GT199900055A (es) 2000-10-07
CN1134434C (zh) 2004-01-14
CA2328876A1 (en) 1999-10-28
AR015765A1 (es) 2001-05-16
AU3420599A (en) 1999-11-08
KR20010042787A (ko) 2001-05-25
EP1073653B1 (de) 2002-08-28
HK1037188A1 (en) 2002-02-01
CN1297449A (zh) 2001-05-30
US6503913B1 (en) 2003-01-07
ID26308A (id) 2000-12-14
ES2181413T3 (es) 2003-02-16

Similar Documents

Publication Publication Date Title
PE20000428A1 (es) Nuevas dihidropirimidinas 2 heterociclicamente sustituidas
PE20000427A1 (es) Nuevas dihidropirimidinas
ES2191484T3 (es) Compuestos heterociclicos como inhibidores de enzimas de rotamasa.
PE20000426A1 (es) Uso de dihidropirimidinas como medicamento y nuevas sustancias
AR038019A1 (es) Naftalenos substituidos con fenilo como agentes estrogenicos
PE20020823A1 (es) Derivados de nucleosidos como inhibidores de polimerasa de arn viral dependiente de arn
NL350075I2 (es)
PE20011348A1 (es) Agentes antivirales de imidazopiridina e imidazopimiridina
GR3034398T3 (en) 2-[1',2',4'-triazol-3'-yloxymethylene]-anilides and their use as pest-control agents
TR200300544T1 (tr) Erimiş siklik bileşimler ve tıbbi kullanımları
TR199902552T2 (xx) Fungisidal triflorometilalkilamino-triazolopirimidinler.
PE20020855A1 (es) Derivados de piperazina azaindoloxoacetico sustituidos con actividad antiviral
PE20011066A1 (es) PIRIDO [2,3-d] PIRIMIDIN-2,7-DIAMINAS INHIBIDORES DE CINASAS
BR0315897A (pt) agentes antiinfecciosos
CO5150150A1 (es) 4-oxo-1,4-dihidro-3-quinoleincarboxamidas como agentes antivirales
PE20001485A1 (es) Derivados de la camptotecina que tienen actividad antitumoral
PE20030497A1 (es) Combinaciones de un inhibidor de pde 5 y otros agentes activos
AR006720A1 (es) Un compuesto derivado de azahexano heterociclico, su uso para la preparacion de una composicion farmaceutica, procedimiento para prepararlo y una composicion farmaceutica que lo comprende
ATE402701T1 (de) N-(8,8,8-trifluorooctyl)-1,5-dideoxy-1,5-imino- - glucitol zur behandlung von hepatitis-virus- infektionen
DE60231901D1 (de) Dna-synthesepromotoren, mit dna-polymerase assoziierte faktoren und nutzung davon
DE69716292D1 (de) Benzopyranderivate
CO5160347A1 (es) Derivados de acido carbamico
PE20040772A1 (es) Composicion y actividad antiviral de derivados de piperazina azaindoloxoaceticos
MX9302169A (es) Fenoxialquilisoxazolas de 1,2,4-oxadiazolilo y su uso como agentes antivirales.
AR022824A1 (es) Inhibidores de metaloproteasa dihetero-sustituida

Legal Events

Date Code Title Description
FA Abandonment or withdrawal